Cegedim partnering with Microsoft

Share this article:
Healthcare customer relationship management (CRM) firm Cegedim Dendrite has inked a deal with Microsoft in an effort to boost the effectiveness of its software offerings for its pharma marketing clients. Financial terms of the deal were not disclosed.

Under the agreement, Cegedim Dendrite gets rights to incorporate the Microsoft SQL Reporting Services, Microsoft Office PerformancePoint Server 2007 and Microsoft SharePoint Server 2007 programs into its CRM software. 

The additions will provide insights that will help guide pharmaceutical marketers more precisely in their promotional efforts, said Cegedim Dendrite VP, CRM solutions and analytics, Subash Vaid. 
“Today's pharmaceutical companies are facing a myriad of pressures when bringing new and existing brands to market. Our alliance with Microsoft will help companies turn massive amounts of data into extremely useful information,” Vaid explained. 
Cegedim Dendrite currently uses Microsoft technology in a large number of solutions, including its flagship sales force effectiveness product dubbed “Mobile Intelligence.” 

Cegedim Dendrite said its next-generation products will also be based on the .NET Framework, as well as Microsoft SQL Server 2008, Windows Vista, Windows Mobile and Microsoft Office SharePoint Server 2007. 

“Pharmaceutical companies struggle with turning large amounts of customer data into actionable information for their sales and marketing departments,” added general manager of Microsoft's Worldwide Manufacturing Group Charles Johnson. “Cegedim Dendrite has chosen to migrate its CRM offerings onto Microsoft's familiar and widely supported platform to help our mutual customers solve that problem.” 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?